INDIVA Signs Cannabis Concentrate Program Agreement With MediPharm Labs

New Cannabis Ventures
By NCV NewswireSep 4, 2018, 7:57 am91 pts
LONDON, ON, Sept. 4, 2018 /CNW/ – INDIVA Limited (the “Company” or “INDIVA”) (TSXV: NDVA) is pleased to announce its wholly-owned subsidiary, INDIVA Inc., has entered into a Cannabis Concentrate Program Agreement (the “Agreement”) with MediPharm Labs Inc. (“MediPharm”). Pursuant to the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Cannabis Rescheduling: Myths Versus Reality 76

Scathing audit of Mass. marijuana regulator finds ‘favoritism,’ lost revenue 76

PharmaCann Opens 4th Ohio Verilife Dispensary in Solon 75

TILT Holdings Sells 2 Massachusetts Dispensaries to In Good Health 73

Canada’s regulated cannabis market has largely overtaken the illicit sector: report 72

Last Week in Weed: August 12- 19, 2025 72

Trump Reviews Recommendation To Highlight Harms Of Marijuana And Other Drugs For Young People 67

Massachusetts could be first state to repeal legal adult-use marijuana sales 66

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.